Drug Manufacturers - Specialty & Generic
Compare Stocks
2 / 10Stock Comparison
HLN vs PG
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
HLN vs PG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Household & Personal Products |
| Market Cap | $41.45B | $341.30B |
| Revenue (TTM) | $22.01B | $86.72B |
| Net Income (TTM) | $3.18B | $12.72B |
| Gross Margin | 63.9% | 50.3% |
| Operating Margin | 21.4% | 23.2% |
| Forward P/E | 22.2x | 21.1x |
| Total Debt | $8.59B | $35.46B |
| Cash & Equiv. | $1.32B | $9.56B |
HLN vs PG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 22 | May 26 | Return |
|---|---|---|---|
| Haleon plc (HLN) | 100 | 132.4 | +32.4% |
| The Procter & Gambl… (PG) | 100 | 105.1 | +5.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HLN vs PG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HLN is the clearest fit if your priority is sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.06, Low D/E 52.2%, current ratio 0.92x
- PEG 2.63 vs PG's 3.78
- Beta 0.06, yield 1.9%, current ratio 0.92x
PG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 36 yrs, beta 0.10, yield 2.8%
- Rev growth 0.3%, EPS growth 8.1%, 3Y rev CAGR 1.7%
- 119.3% 10Y total return vs HLN's 31.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 0.3% revenue growth vs HLN's -4.0% | |
| Value | PEG 2.63 vs 3.78 | |
| Quality / Margins | 14.7% margin vs HLN's 14.5% | |
| Stability / Safety | Beta 0.06 vs PG's 0.10, lower leverage | |
| Dividends | 2.8% yield, 36-year raise streak, vs HLN's 1.9% | |
| Momentum (1Y) | -5.6% vs HLN's -11.7% | |
| Efficiency (ROA) | 10.0% ROA vs PG's 10.0%, ROIC 7.6% vs 20.1% |
HLN vs PG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HLN vs PG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
PG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PG is the larger business by revenue, generating $86.7B annually — 3.9x HLN's $22.0B. Profitability is closely matched — net margins range from 14.7% (PG) to 14.5% (HLN). On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $22.0B | $86.7B |
| EBITDAEarnings before interest/tax | $5.3B | $21.9B |
| Net IncomeAfter-tax profit | $3.2B | $12.7B |
| Free Cash FlowCash after capex | $3.1B | $15.0B |
| Gross MarginGross profit ÷ Revenue | +63.9% | +50.3% |
| Operating MarginEBIT ÷ Revenue | +21.4% | +23.2% |
| Net MarginNet income ÷ Revenue | +14.5% | +14.7% |
| FCF MarginFCF ÷ Revenue | +14.2% | +17.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.4% | +7.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +18.8% | +5.8% |
Valuation Metrics
HLN leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 19.0x trailing earnings, HLN trades at a 15% valuation discount to PG's 22.4x P/E. Adjusting for growth (PEG ratio), HLN offers better value at 2.25x vs PG's 4.01x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $41.4B | $341.3B |
| Enterprise ValueMkt cap + debt − cash | $51.3B | $367.2B |
| Trailing P/EPrice ÷ TTM EPS | 19.01x | 22.44x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.22x | 21.14x |
| PEG RatioP/E ÷ EPS growth rate | 2.25x | 4.01x |
| EV / EBITDAEnterprise value multiple | 13.62x | 15.76x |
| Price / SalesMarket cap ÷ Revenue | 2.83x | 4.05x |
| Price / BookPrice ÷ Book value/share | 1.87x | 6.86x |
| Price / FCFMarket cap ÷ FCF | 15.47x | 24.30x |
Profitability & Efficiency
HLN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
PG delivers a 23.8% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $20 for HLN. HLN carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to PG's 0.68x. On the Piotroski fundamental quality scale (0–9), HLN scores 8/9 vs PG's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +19.9% | +23.8% |
| ROA (TTM)Return on assets | +10.0% | +10.0% |
| ROICReturn on invested capital | +7.6% | +20.1% |
| ROCEReturn on capital employed | +8.6% | +23.0% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.52x | 0.68x |
| Net DebtTotal debt minus cash | $7.3B | $25.9B |
| Cash & Equiv.Liquid assets | $1.3B | $9.6B |
| Total DebtShort + long-term debt | $8.6B | $35.5B |
| Interest CoverageEBIT ÷ Interest expense | 7.80x | 487.21x |
Total Returns (Dividends Reinvested)
Evenly matched — HLN and PG each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HLN five years ago would be worth $13,169 today (with dividends reinvested), compared to $12,240 for PG. Over the past 12 months, PG leads with a -5.6% total return vs HLN's -11.7%. The 3-year compound annual growth rate (CAGR) favors HLN at 3.4% vs PG's 0.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -5.6% | +4.5% |
| 1-Year ReturnPast 12 months | -11.7% | -5.6% |
| 3-Year ReturnCumulative with dividends | +10.4% | +1.9% |
| 5-Year ReturnCumulative with dividends | +31.7% | +22.4% |
| 10-Year ReturnCumulative with dividends | +31.7% | +119.3% |
| CAGR (3Y)Annualised 3-year return | +3.4% | +0.6% |
Risk & Volatility
Evenly matched — HLN and PG each lead in 1 of 2 comparable metrics.
Risk & Volatility
HLN is the less volatile stock with a 0.06 beta — it tends to amplify market swings less than PG's 0.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PG currently trades 85.4% from its 52-week high vs HLN's 81.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.06x | 0.10x |
| 52-Week HighHighest price in past year | $11.42 | $170.99 |
| 52-Week LowLowest price in past year | $8.71 | $137.62 |
| % of 52W HighCurrent price vs 52-week peak | +81.5% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 36.0 | 53.7 |
| Avg Volume (50D)Average daily shares traded | 8.0M | 7.2M |
Analyst Outlook
PG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates HLN as "Buy" and PG as "Buy". Consensus price targets imply 10.8% upside for PG (target: $162) vs 9.6% for HLN (target: $10). For income investors, PG offers the higher dividend yield at 2.75% vs HLN's 1.94%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $10.20 | $161.88 |
| # AnalystsCovering analysts | 4 | 52 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | +2.8% |
| Dividend StreakConsecutive years of raises | 2 | 36 |
| Dividend / ShareAnnual DPS | $0.13 | $4.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +1.9% |
PG leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). HLN leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
HLN vs PG: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is HLN or PG a better buy right now?
For growth investors, The Procter & Gamble Company (PG) is the stronger pick with 0.
3% revenue growth year-over-year, versus -4. 0% for Haleon plc (HLN). Haleon plc (HLN) offers the better valuation at 19. 0x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate Haleon plc (HLN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HLN or PG?
On trailing P/E, Haleon plc (HLN) is the cheapest at 19.
0x versus The Procter & Gamble Company at 22. 4x. On forward P/E, The Procter & Gamble Company is actually cheaper at 21. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Haleon plc wins at 2. 63x versus The Procter & Gamble Company's 3. 78x.
03Which is the better long-term investment — HLN or PG?
Over the past 5 years, Haleon plc (HLN) delivered a total return of +31.
7%, compared to +22. 4% for The Procter & Gamble Company (PG). Over 10 years, the gap is even starker: PG returned +119. 3% versus HLN's +31. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HLN or PG?
By beta (market sensitivity over 5 years), Haleon plc (HLN) is the lower-risk stock at 0.
06β versus The Procter & Gamble Company's 0. 10β — meaning PG is approximately 70% more volatile than HLN relative to the S&P 500. On balance sheet safety, Haleon plc (HLN) carries a lower debt/equity ratio of 52% versus 68% for The Procter & Gamble Company — giving it more financial flexibility in a downturn.
05Which is growing faster — HLN or PG?
By revenue growth (latest reported year), The Procter & Gamble Company (PG) is pulling ahead at 0.
3% versus -4. 0% for Haleon plc (HLN). On earnings-per-share growth, the picture is similar: Haleon plc grew EPS 12. 5% year-over-year, compared to 8. 1% for The Procter & Gamble Company. Over a 3-year CAGR, PG leads at 1. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HLN or PG?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.
0% net margin versus 15. 1% for Haleon plc — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 22. 4% for HLN. At the gross margin level — before operating expenses — HLN leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HLN or PG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Haleon plc (HLN) is the more undervalued stock at a PEG of 2. 63x versus The Procter & Gamble Company's 3. 78x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, The Procter & Gamble Company (PG) trades at 21. 1x forward P/E versus 22. 2x for Haleon plc — 1. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PG: 10. 8% to $161. 88.
08Which pays a better dividend — HLN or PG?
All stocks in this comparison pay dividends.
The Procter & Gamble Company (PG) offers the highest yield at 2. 8%, versus 1. 9% for Haleon plc (HLN).
09Is HLN or PG better for a retirement portfolio?
For long-horizon retirement investors, The Procter & Gamble Company (PG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
10), 2. 8% yield, +119. 3% 10Y return). Both have compounded well over 10 years (PG: +119. 3%, HLN: +31. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HLN and PG?
These companies operate in different sectors (HLN (Healthcare) and PG (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.